Detection of circulating epithelial cells in the blood of patients with breast cancer: Comparison of three techniques

British Journal of Cancer

Volumn 92, Issue 5, 2005, Pages 906-912

  Ring, A E ^a   Zabaglo, L ^a   Ormerod, M G ^a   Smith, I E ^a   Dowsett, M ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Circulating tumour cells; Micrometastases

Indexed keywords

COMPLEMENTARY DNA; CYTOKERATIN 19; MAMMAGLOBIN; PEPTIDE; PROLACTIN; PROLACTIN INDUCIBLE PEPTIDE; RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMETRY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOMAGNETIC SEPARATION; INTERMETHOD COMPARISON; LASER SCANNING CYTOMETRY; METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL;

ADULT; AGED; BASE SEQUENCE; BREAST NEOPLASMS; DNA PRIMERS; EPITHELIAL CELLS; FEMALE; HUMANS; KERATINS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 16244393669     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602418     Document Type: Article

References (27)

1. Aerts J, Wynendaele W, Paridaens R, Christiaens MR, van den Bogaert W, van Oosterom AT, Vandekerckhove F (2001) A real-time quantitative reverse transcriptase polymerase chain reaction (RT-PCR) to detect breast carcinoma cells in peripheral blood. Ann Oncol 12: 39-46
2. Baker MK, Mikhitarian K, Osta W, Callahan K, Hoda R, Brescia F, Kneuper-Hall R, Mitas M, Cole DJ, Gillanders WE (2003) Molecular detection of breast cancer cells in the peripheral blood of advanced-stage breast cancer patients using multimarker real-time reverse transcription-polymerase chain reaction and a novel porous barrier density gradient centrifugation technology. Clin Cancer Res 9: 4865-4871
3. Bartek J, Bartkova J, Schneider J, Taylor-Papadimitriou J, Kovarik J, Rejthar A (1986) Expression of monoclonal antibody-defined epitopes of keratin 19 in human tumours and cultured cells. Eur J Cancer Clin Oncol 22: 1441-1452
4. Bosma AJ, Weigelt B, Lambrechts AC, Verhagen OJ, Pruntel R, Hart AAM, Rodenhuis S, van't Veer LJ (2002) Detection of circulating breast tumor cells by differential expression of marker genes. Clin Cancer Res 8: 1871-1877
5. Brandt B, Roetger A, Heidi S, Jackisch C, Lelle RJ, Assmann G, Zanker KS (1998) Isolation of blood-borne epithelium-derived c-erbB-2 oncoprotein-positive clustered cells from the peripheral blood of breast cancer patients. Int J Cancer 76: 824-828
6. Clark JW, Snell L, Shiu RP, Orr FW, Maitre N, Vary CPH, Cole DJ, Watson PH (1999) The potential role for prolactin-inducible protein (PIP) as a marker of human breast cancer micrometastasis. Br J Cancer 81: 1002-1008
7. European ISHAGE Working Group for the Standardisation of Tumour Cell Detection (1999) Standardisation of the immunocytochemical detection of cancer cells in BM and blood: I. Establishment of objective criteria for the evaluation of immunostained cells. Cytotherapy 1: 377-388
8. Lambrechts AC, Bosma AJ, Klaver SG, Top B, Perebolte L, van't Veer LJ, Rodenhuis S (1999) Comparison of immunocytochemistry, reverse transcriptase polymerase chain reaction, and nucleic acid sequence-based amplification for the detection of circulating breast cancer cells. Breast Cancer Res Treat 56: 219-231
9. Mitas M, Mikhitarian K, Almeida JS, Gillanders WE, Cole DJ (2003) Application of population-based statistical theory to a multi-institutional prospective cohort study indicates that mammaglobin is the most reliable marker for the detection of micrometastatic cancer. San Antonio Breast Cancer Symposium abstract 1018
10. Moll R (1994) Cytokeratins in the histological diagnosis of malignant tumors. Int J Biol Markers 9: 63-69
11. Muller PY, Janovjak H, Miserez AR, Dobbie Z (2002) Processing of gene expression data generated by quantitative real-time RT-PCR. Biotechniques 32: 1372-1374, 1376, 1378-1379
12. Pachmann K, Heiss P, Demel U, Tilz G (2001) Detection and quantification of small numbers of circulating tumour cells in peripheral blood using laser scanning cytometer (LSC). Clin Chem Lab Med 39: 811-817
13. Racila E, Euhus D, Weiss AJ, Rao C, McConnell J, Terstappen LW, Uhr JW (1998) Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci USA 95: 4589-4594
14. Ring A, Smith IE, Dowsett M (2004) Circulating tumour cells in breast cancer. Lancet Oncol 5: 79-88
15. Ruud P, Fodstad O, Hovig E (1999) Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cells. Int J Cancer 80: 119-125
16. Schoenfeld A, Kruger KH, Gomm J, Sinnett HD, Gazet JC, Sacks N, Bender HG, Luqmani Y, Coombes RC (1997) The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19. Eur J Cancer 33: 854-861
17. Silva AL, Tome MJ, Correia AE, Passos-Coelho JL (2002) Human mammaglobin RT-PCR assay for detection of occult breast cancer cells in hematopoietic products. Ann Oncol 13: 422-429
18. Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI, Borgen PI, Clark GM, Edge SB, Hayes DF, Hughes LL, Hutter RV, Morrow M, Page DL, Recht A, Theriault RL, Thor A, Weaver DL, Wieand HS, Greene FL (2002) Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 20: 3628-3636
19. Slade MJ, Smith BM, Sinnett HD, Cross NC, Coombes RC (1999) Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer. J Clin Oncol 17: 870-879
20. Smith BM, Slade MJ, English J, Graham H, Luchtenborg M, Sinnett HD, Cross NCP, Coombes RC (2000) Response of circulating tumor cells to systemic therapy in patients with metastatic breast cancer: comparison of quantitative polymerase chain reaction and immunocytochemical techniques. J Clin Oncol 18: 1432-1439
21. Stathopoulou A, Gizi A, Perraki M, Apostolaki S, Malamos N, Mavroudis D, Georgoulias V, Lianidou ES (2003) Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the LightCycler system. Clin Cancer Res 9: 5145-5151
22. Stathopoulou A, Vlachonikolis I, Mavroudis D, Perraki M, Kouroussis C, Apostolaki S, Malamos N, Kakolyris S, Kostakis A, Xenidis N, Reppa D, Georgoulias V (2002) Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance. J Clin Oncol 20: 3404-3412
23. Taback B, Chan AD, Kuo CT, Bostick PJ, Wang HJ, Giuliano AE, Hoon DS (2001) Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease. Cancer Res 61: 8845-8850
24. Vona G, Sabile A, Louha M, Sitruk V, Romana S, Schutze K, Capron F, Franco D, Pazzagli M, Vekemans M, Lacour B, Brechet C, Paterlini-Brechot P (2000) Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulating tumor cells. Am J Pathol 156: 57-63
25. Witzig TE, Bossy B, Kimlinger T, Roche PC, Ingle JN, Grant C, Donohue J, Suman VJ, Harrington D, Tuerro-Bueno J, Kauer KD (2002) Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy. Clin Cancer Res 8: 1085-1091
26. Zabaglo L, Ormerod MG, Parton M, Ring A, Smith IE, Dowsett M (2003) Cell filtration-laser scanning cytometry for the characterisation of circulating breast cancer cells. Cytometry 55A: 102-108
27. Zach O, Kasparu H, Krieger O, Hehenwarter W, Girschikofsky M, Lutz D (1999) Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA. J Clin Oncol 17: 2015-2019